Friday, July 07, 2017 8:13:45 PM
I never claimed to know when trial results are coming out. They will come out when completed and there is an announcement. Despite your false claim in post 9757 that I am an Internet insider trying to misdirect facts, my only claims are listed below and they are all verifiable. It is also verifiable that you falsely stated that
1. Irving lied to all shareholders
2. Irving said results will be right after the trial
3. The supposed letters to SEC and FINRA are without any evidence
4. When Sucanon was correctly referred to as a drug, falsely stated "Not according to the FDA"
I note that none of the above was addressed, yet I am told to give an exact date when the study will be released (a change of subject). Evidence Was given in minute detail.
By the way my "verbose affirmation" was not an affirmation of anything you stated. On the contrary, my evidence definitively disproved all your statements above. If one wants to call it verbose so be it. The evidence is listed so any can verify the information for themselves. Far better in my opinion to be "verbose" and list the evidence than to mislead by verifiably altering, for example, a Consumer Reports article to falsely implicate this company and its product, all the while calling it a "verbatim excerpt". Once again the evidence for that is below and the evidence is clear and irrefutable.
You state in post 9651 "It's an exact excerpt from CR"
Let's consult the definition of exact from Merriam Webster "Strictly and completely in accordance with fact; not deviating from truth or reality. Since the article has been provably modified it is neither "exact" nor verbatim as falsely claimed. For completeness, the verb definition of exact is included also in case any find it applicable:
" to demand and get (something, such as payment or revenge) especially by using force or threats"
Each time the Consumer Reports article has been posted as supposed evidence that FDA warns against Sucanon or 'types of products' like Sucanon, the subject sentence is left out of the middle of the claimed "verbatim excerpt" (post 6475, 6489 and others).
It reads : "It warned 15 companies last week about the illegal marketing of certain diabetes products, including Glucocil, Glytain, ProBeta’s Gynmena Sylvestre, and Zostrix Joint and Arthritis Pain Relief Cream. " Note that Sucanon is not mentioned in the article and has not been sold in the US.
Further, IF the article was applicable, why would it be necessary to leave out the subject sentence? It is claimed a "verbatim excerpt" in many previous posts, when it is not which leads to a false conclusion. That is a notorious omission and the falsity easily and definitively established.
Read the complete unedited article here:
http://www.consumerreports.org/cro/news/2013/07/diabetes-treatment-alternatives/index.htm
Let's consult the definition of verbatim: "in exactly the same words that were used originally", which your post is clearly not. More disturbing, when the error is pointed out, it is incorrectly repeated again for the stated purpose of "scaring others away" as stated in post 4550.
This is further evidence of my contention that no credible information has been put forth of a scam or fraudulent actions by this company. If the "evidence" has to have the subject sentence removed while falsely claiming a "verbatim excerpt" and attempting to lead others to an incorrect conclusion, then that is not evidence at all. In court it would be false testimony. If the company is a scam and fraudulent as claimed, there would be plenty of supporting information for those claims. Instead, information is falsely and surreptitiously edited to make it appear to support the false claim and conclusion as above.
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM